ALK4290 [1251528-23-0]

MedChem Express

ALK4290 [1251528-23-0]

10

1251528-23-0

Research Use Only

99.79

C27H34ClN5O3

512.04

ALK4290 (AKST4290) is a potent and orally active CCR3 inhibitor extracted from patent US20130261153A1, compound Example 2, with a Ki of 3.2 nM for hCCR3[1]. ALK4290 can be used for the research of neovascular age-related macular degeneration and Parkinsonism[2][3].

O=C(C1=CC(NC([C@@H](CC2)N(C3CCN(CC4=CC=C(Cl)C(C)=C4)CC3)C2=O)=O)=NC(C)=C1)N(C)C

-20°C,2°C to 8°C

12131703